FDA Drug recall D-1459-2016
Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90
- FDA Drug
- Class II
- terminated
- Published 2016-08-24
On 2016-08-24 the FDA classified a Class II recall of Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90 by Golden State Medical Supply, citing failed Dissolution Specifications: Out-of-specification results in retained sample.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1459-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-08-03 |
| Published | 2016-08-24 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Golden State Medical Supply |
| Distribution | US |
Product
Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90
Reason
Failed Dissolution Specifications: Out-of-specification results in retained sample.
Identifiers
| code_info | Lot #: GS011692, GS011938, Exp 10/2017; GS012638, GS012639, Exp 11/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1459-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.